Skip to main content

Coloplast A/S – Invitation to Coloplast’s Capital Markets Day on 2 September 2025

The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)
Ellehammersvej 20, 2770 Kastrup
from 10.30 – 17.00 CEST
(Central European Summer Time)

Coloplast invites institutional investors, equity analysts and media to attend our 2025 Capital Markets Day.
The event will be held in person at Clarion Hotel in Copenhagen, Denmark, with the option to join virtually for the plenary session.
The purpose of the event is to give institutional investors and financial analysts an introduction to the new 5-year strategy for the company, as well as to provide the opportunity to meet with the broader Management team.
The day will start with a plenary session, covering the introduction of the new Group strategy, a financial update, and the strategy for the Chronic Care businesses. In the afternoon, participants will be split into groups and rotate between four Q&A breakout sessions. Participation in the breakout sessions will be in-person only (with a replay of the presentations available after the event).
The formal program will end at 17.00, followed by an opportunity to meet the Coloplast management team in an informal setting.

Agenda in CEST
10.00 – 10.30  Registration
10.30 – 12.30  Plenary session: Group strategy and financials, strategy for Chronic Care and Voice and Respiratory Care
12.30 – 13.00  Lunch break
13.00 – 17.00  Q&A breakout sessions (incl. breaks)
17.00 – 18.30  Social activity (on premise)

Coloplast representatives

Plenary session:  
  Lars Rasmussen, Interim President and CEO
  Anders Lonning-Skovgaard, Executive Vice President, CFO
  Nicolai Buhl, Executive Vice President, Chronic Care
  Caroline Vagner Rosenstand, Executive Vice President, Voice & Respiratory Care

Breakout sessions:  
  Chronic Care deep dive:
  Mike DelVacchio, Senior Vice President, North America
  Thomas Bruhn, Senior Vice President, Emerging Markets

  Advanced Wound Care:
  Fertram Sigurjonsson, Founder and President, Kerecis
  Bernd Greiner, Senior Vice President, Adv. Wound Dressings

  Interventional Urology:
  Thomas NP Johns Jr, Executive Vice President, Interventional Urology

  Global Operations and People & Culture:
  Allan Rasmussen, Executive Vice President, Global Operations
  Dorthe Rønnau, Executive Vice President, People & Culture

In-person participation
If you wish to join us in-person and attend the plenary session and the Q&A breakout sessions, please register by sending an email to CMD2025@coloplast.com stating your full name, company, contact phone number and itinerary (if relevant).
Kindly register before Friday, 15 August 2025.

Virtual participation
Virtual participation will be possible for the plenary session.
A link for the webcast of the plenary sessions will be available on our website closer to the date.

For more information,
please contact:

Aleksandra Dimovska, Vice President
Direct tel.: +45 4911 2458
E-mail: dkadim@coloplast.com 

Simone Dyrby Helvind, Sr. Manager  
Direct tel.: +45 4911 2981
E-mail: dksdk@coloplast.com 

Julie Sommer Müggler, Coordinator   
Direct tel.: +45 4911 3161
Email: dkjusm@coloplast.com 

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.